3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Stomach Neoplasms
14
Prostatic Neoplasms
13
Colorectal Neoplasms
13
Neoplasms
12
Pancreatic Neoplasms
10
Endometrial Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Lung Neoplasms
7
Colonic Neoplasms
7
Neoplasm Metastasis
6
Carcinoma, Hepatocellular
6
Oropharyngeal Neoplasms
5
Multiple Myeloma
5
Mouth Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Sarcoma
4
Recurrence
4
Rectal Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Esophageal Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Gastrointestinal Stromal Tumors
3
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
9
Ciprofloxacin
7
gamma-Globulins
3
Voriconazole
3
Fluconazole
3
Daptomycin
3
Antibiotic Prophylaxis
3
Amoxicillin-Potassium Clavulanate Combination
3
Whole-Body Irradiation
2
Vancomycin
2
Trimethoprim
2
Sulfamethoxazole
2
Saline Solution
2
Ribavirin
2
Peripheral Blood Stem Cell Transplantation
2
Pentetic Acid
2
Melphalan
2
Itraconazole
2
Immunoglobulins, Intravenous
2
Fosfomycin
2
Ethanol
2
Cyclophosphamide
2
Cefazolin
2
Caspofungin
2
ziprasidone
1
tocilizumab
1
telavancin
1
telaprevir
1
talquetamab
1
soybean oil, phospholipid emulsion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Infections
×
Observation
×
Clear all
NCT02624440
2015-12-08
SUTRICA
Aalborg University Hospital
Phase 2
Unknown
300 enrolled